Skip to main content

Table 1 Demographic data, medical history, and baseline characteristics of patients with sepsis-induced ARDS. Data are presented as n (N%), where n stands for the patient number and N for the percentage in the group

From: Dexmedetomidine administration is associated with reduced mortality in patients with sepsis-induced acute respiratory distress syndrome: a retrospective study

 

Control (n = 102)

DEX (n = 106)

p

Age (year)

69.0 (65.0–76.0)

69.0 (61.8–76.0)

0.507

Gender (male), n. (%)

79 (77.5%)

84 (79.2%)

0.753

ICU stay (day)

15.0 (11.8–19.3)

15.0 (12.0–19.0)

0.557

Smoking history, n. (%)

28 (27.5%)

44 (41.5%)

0.033

Comorbidity, n. (%)

   

 Hypertension

42 (41.2%)

42 (39.6%)

0.819

 Diabetes

24 (23.5%)

19 (17.9%)

0.318

 Coronary heart diseases

16 (15.7%)

13 (12.3%)

0.476

 Bronchitis

13 (12.7%)

24 (22.6%)

0.062

Primary diagnosis, n. (%)

   

 Pneumonia (non-viral)

82 (80.4%)

76 (72.4%)

0.175

 Respiratory failure

47 (46.1%)

36 (34.0%)

0.074

 AECOPD

27 (26.5%)

23 (21.7%)

0.421

 Multiple trauma

8 (7.8%)

18 (17.0%)

0.046

 Intracerebral hemorrhage

2 (2.0%)

4 (3.8%)

0.714

Cause of ARDS, n. (%)

   

 Lung infection

57 (55.9%)

51 (48.1%)

0.262

 Trauma

26 (25.5%)

25 (23.6%)

0.749

 Surgery

15 (14.7%)

26 (24.5%)

0.075

 Acute pancreatitis

11 (10.8%)

15 (14.2%)

0.463

 Aspiration

9 (8.8%)

10 (9.4%)

0.879